Technology
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines – News-Medical.Net
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines…
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The lipid nanoparticle (LNP) delivery vehicles have inherent immunostimulatory properties that can induce adverse events such as allergic reactions.
Now, Ronald Levy and colleagues from Stanford University…
-
General20 hours agoDefence minister won’t say if security agencies or Trump administration pushed for Darwin Port backflip
-
General16 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
General19 hours agoAsian, European stocks nosedive on tariff turmoil
-
General16 hours agoAsia stocks plunge, HK suffers steepest fall since 1997